Insights and analysis on emerging litigation trends, class actions, and legal intelligence.
For two years, AI developers have won copyright fights on fair use. A new Meta ruling points the litigation somewhere they can't defend as easily: not how the data was used, but how it was pirated. Why Strike 3 v. Meta is a roadmap for every AI copyright case already on file.
Two California drivers sued Motorola over its license-plate network. Inside Rojas v. Motorola, the SB 34 operator theory, and why ALPR vendors are next.
One contract clause now sits at the center of antitrust cases against Amazon, Steam, and Microsoft. Here's why price-parity provisions (MFN clauses) became a billion-dollar liability, and where the theory is still untested.
Amazon's $20.5M nitrate deal is the first Big Tech data-center water settlement, and a template. Why data center litigation is replacing regulation, and who's exposed next.
Plaintiffs' firms now call campus meal swipes "gift cards." Inside the Yale and Rutgers suits, the gift-card-act theory, and which schools face exposure.
Multiple class actions filed, investigations are active, and billions in potential damages. California's ALPR privacy law is fueling a litigation wave against businesses using Flock Safety cameras, and it's just getting started.
States are challenging prediction markets under gambling laws. A legal analysis of lawsuits against Kalshi, Polymarket, and Crypto.com over sports event contracts.
Preferential pricing and supplier retailer relationships are drawing renewed Robinson Patman scrutiny. This analysis explains why older pricing practices are reappearing as litigation risk and what it signals for consumer brands.
Recent ERISA class actions targeting voluntary benefits signal a shift in fiduciary litigation strategy. This analysis explains why employee paid benefits and consultant compensation are becoming focal points of new ERISA exposure.
How platform design and lead allocation can create RESPA mortgage steering liability, using Armstrong v. Zillow to explain emerging risk for real estate and fintech platforms.
Khan v. Figma highlights how generative AI training on customer data without clear consent is creating new litigation risk under contract, privacy, and trade secret law.
DOJ’s Bulk Sensitive Data Rule limits cross-border transfers to China, Russia, and others. Explore litigation risks for ad tech, apps, brokers, genomics, and finance.
Kratom lawsuits and looming FDA and DEA actions threaten manufacturers, retailers, and online platforms; uncover key litigation risks and defense strategies.
Discover how right-of-publicity lawsuits are expanding beyond celebrities to target data platforms like ZoomInfo and Avvo for monetizing personal identities without consent. Learn key legal trends, state laws, and litigation risks.
Explore the emerging wave of video game addiction lawsuits, the next major frontier in mass tort litigation. Learn about potential legal theories, recent landmark cases, and challenges facing litigators navigating behavioral design and psychological harms linked to gaming addiction.
Discover emerging legal theories of AI liability, including biometric privacy, consumer protection pitfalls, workplace discrimination, education fairness, and financial transparency. Learn how companies can proactively navigate these critical litigation risks.
Explore how dark patterns in games and manipulative design tactics like loot boxes and hard-to-cancel subscriptions are facing growing legal challenges. Discover key lawsuits reshaping consumer protection and gaming industry practices.
Emerging privacy litigation targets mobile SDKs for unauthorized data collection. Learn how lawsuits against Amazon, Meta, Twilio, and others are shaping the legal landscape. Stay ahead with insights on compliance, consent, and regulatory risks in SDK-related privacy claims.
Egg producers face DOJ antitrust scrutiny amid record-high prices. Discover how alleged price fixing, industry risks, and market manipulation could reshape future litigation.
Uncover the antitrust battle against PBMs amid soaring insulin prices. Explore key legal challenges, regulatory actions, and emerging litigation trends reshaping drug pricing.
Major brands face lawsuits and record FTC penalties in 2025 over false "Made in USA" claims. Learn the latest legal standards, high-profile cases, and how patriotic imagery creates liability risks.